This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Sol-Gel Technologies

Drug Names(s): S6G5T-1, S6G5T-3, benzoyl peroxide/tretinoin

Description: TWIN is a non-antibiotic topical cream for the treatment of acne vulgaris (acne). TWIN contains a fixed-dose combination of benzoyl peroxide and tretinoin, which are separately encapsulated in silica using Sol-Gel's proprietary technology. The silica microcapsule protects tretinoin from oxidative decomposition by benzoyl peroxide, thereby enhancing commercial shelf-life. The silica shell also controls the release rate of the drugs and creates a barrier between the drugs and the skin which could increase the tolerability of TWIN on acne-affected skin.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug